Associate Director, SEC Reporting & Technical Accounting

<div class="content-intro"><h3><strong>Join our Mission to Protect Humankind!</strong></h3> <div>Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. </div> <div> </div> <div><strong>WHAT</strong> we do is every bit as important as <strong>HOW</strong> we do it! Our work together is guided by four enduring core values:</div> <div> </div> <div>*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.</div> <div> </div> <div>*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.</div> <div> </div> <div>*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.</div> <div> </div> <div>*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.</div></div><h3><strong>Summary:</strong></h3> <p>The Associate Director, SEC Reporting Technical Accounting will serve as a key contributor to the company’s external reporting and technical accounting function. Reporting to the Senior Director, Technical Accounting SEC Reporting, this role will be highly hands-on, owning the preparation and execution of SEC filings and technical accounting analyses while also managing one direct report. </p> <p>This role is ideal for a technically strong accounting professional who enjoys operating in the details, partnering cross-functionally, and helping build processes in a growing public biotechnology company. </p> <h3>Essential Functions:</h3> <p>SEC Reporting (Hands-On Execution) </p> <ul> <li>Own the preparation of quarterly and annual SEC filings, including Forms 10-Q, 10-K, and 8-K </li> <li>Prepare and/or review primary financial statements, footnotes, and related disclosures in accordance with U.S. GAAP and SEC requirements </li> <li>Draft and support MDA disclosures, with emphasis on RD, GA, stock-based compensation, and other pre-revenue biotech-specific areas </li> <li>Coordinate the quarterly close-to-reporting process across Accounting, FPA, Legal, and external auditors </li> <li>Support earnings release tie-outs and disclosure controls </li> </ul> <p>Technical Accounting </p> <ul> <li>Support technical accounting assessments and documentation for complex transactions, including: </li> <li>Collaboration, licensing, and RD-related arrangements </li> <li>Equity and equity-linked financing transactions </li> <li>Other complex and other non-routine transactions </li> <li>Research new accounting standards and SEC guidance; assess applicability and implementation impact </li> <li>Draft clear, well-supported technical accounting memos and communicate conclusions to stakeholders </li> </ul> <p>People Management </p> <ul> <li>Manage and mentor one direct report, providing coaching, review, and development support </li> <li>Review work products to ensure accuracy, quality, and adherence to timelines </li> <li>Foster strong execution discipline and continuous improvement within the reporting function </li> </ul> <p>Process Improvement Scaling </p> <ul> <li>Help design and enhance scalable SEC reporting and technical accounting processes as the company grows </li> <li>Partner with cross-functional teams to ensure accounting and reporting considerations are incorporated into business decisions </li> <li>Support SOX and internal control docum ... (truncated, view full listing at source)